Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision for a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. Deliveries will be required from 1 August 2018 to 31 July 2020 with an option to extend for up to an additional 24 months.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| AstraZeneca UK Ltd | 03674842 | ~£0 estimated from lot values | LOBBYIST FTI Consulting LLP (6 quarters) Incisive Health Ltd (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
Government spending data: This supplier has received £201,701,630 in 43 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2020-06-29 to 2026-03-05). View full payment history →